Medical technology startups, 2011 to 2012

Medical technology companies that have been founded and identified from September 2011 to September 2012 (and included in the Medtech Startups Database) cover a wide range of clinical and technology focus.

Ranked by frequency of the clinical/technology areas in which these companies are competing (they may concurrently compete in several):

Source:  MedMarket Diligence Medtech Startups Database.

The specific technologies under development or at the focus of each company are listed below:

  • Hydrogel-based tissue expanders
  • Systems to prepare tissue for prosthetic implants and grafts.
  • Implants for internal compression or distraction of, for example, bone fractures, fusions, and osteotomies.
  • Devices for heart and vascular, initially developing a catheter-delivered heart valve.
  • Imaging and microfluidics based system to detect cancer.
  • Developing system for detecting pressure-induced ischemia to assist in prevention and treatment of pressure ulcers.
  • Fentanyl iontophoretic transdermal drug delivery system.
  • Implants and other devices for treatment of injured or damaged shoulders.
  • Implants for reducing intraocular pressure
  • Minimally invasive fracture fixation systems to be used in load bearing fractures.
  • Developing an intragastric implant for treatment of obesity and diabetes.
  • Kidney stone retention and retrieval devices.
  • Developing a novel class of compounds for treatment of cardiovascular diseases and metabolic syndrome by exploiting novel biology, associated with mitochondria biogenesis and stabilization.
  • Undisclosed medical technology.
  • Minimally invasive spinal implant to stabilize spine and minimize twisting that can cause back pain.
  • Stroke detection and other products in neurophysiology assessment.
  • Devices to monitor gastrointestinal bleeding and related diseases.
  • Antimicrobial materials.
  • Drug-eluting implant to reduce risk of lung cancer recurrence.
  • Bioabsorbable drug-eluting stent using novel biomaterials, drug and drug delivery technology.
  • Orthopedic biologics.
  • Bioresorbable scaffold for treating occlusive disease in the superficial femoral artery.
  • Patient-controlled device that helps patients recover from knee surgery.
  • Device that stimulates production of natural tears for patients with dry eye disesse.
  • Ventricular assist devices.
  • Glucose monitoring using test strip that connects to smartphones.
  • Hemostasis device for use with vascular access in dialysis.
  • Transcutaneous near field communications chip for tracking implants.
  • Peripheral intravenous (PIV) fluid/medication delivery systems.
  • Hemostatic gauze compression bandage incorporating salmon-derived proteins.
  • Instruments for office-based hysteroscopy.
  • Focused x-rays for radiation therapy with reduced exposure times and adverse collateral tissue effects.
  • Therapeutic cooling in the spinal cord.
  • Technologies for vascular access.
  • Regenerative medicine company developing products for skin, hair and nails.
  • In situ formation of surgical implants.
  • Orthopedic implant prostheses
  • Annuloplasty ring for mitral/tricuspid valve repair
  • Microinjection technology for ophthalmic drug delivery.
  • Undisclosed technology for the treatment of obstructive sleep apnea.
  • Technology to enable office-based myringotomy tube procedures.
  • Hydrogel technology for the prevention of post-surgical adhesions.
  • Organ preservation and transport systems for transplant organs.
  • Obesity device technology
  • Endovascular stapling system
  • Device for the treatment of scoliosis in children.
  • Drug delivery technology.
  • Cannulas and other instruments for use in liposuction and other cosmetic procedures.
  • Wound management products including protegodome, a hard, dome-shaped bandage to protect wounds from impact.
  • Regenerative bandage for the eye that absorbs, dissolves and rapidly heals wounds.
  • Cryoablation for chest and airway applications.
  • Cervical and lumbar prosthetic disc replacement devices.
  • Regenerative medicine based on stromal vascular fraction derived from adult adipose tissue.
  • Minimally invasive correction of hallux valgus.
  • Devices for the treatment of venous disease.
  • Undisclosed medical device technologies.
  • Motion- and depth-sensing device for use in surgical navigation.
  • Device to facilitate insertion of intrauterine device for birth control.
  • Undisclosed medical technologies.
  • Developing nanoparticcles for use in ophthalmology.
  • Less invasive interventional products to treat patients with hemorrhagic stroke.
  • Proximal femur fracture fixation.
  • Minimally invasive, low cost surgery such as for prostatectomy.
  • Fiber optic catheter for removal of tumors and delivery of drugs, including for lung cancer.
  • Implant polymer for bone and vascular lesions.
  • Products to eliminate preventable contamination during invasive medical procedures.
  • Arrhythmia mapping catheters.
  • Electrophysiology (EP) recording systems for the treatment of atrial fibrillation.
  • Reusable surgical trays.
  • Biodegradable implant for treatment of stress urinary incontinence.
  • Foam device to stabilize and position patients for surgical procedures.
  • Treatment for fecal incontinence
  • Surgical simulation technology for spine surgery.
  • Intraoperative nerve monitoring.
  • Preventive surgical technology to treat the risk of hip fracture
  • Regenerative medicine company developing tissue scaffolds.
  • Technology to clean laparoscopic lenses.
  • Smartphone-enabled otoscope for remote diagnosis of pediatric ear infections.
  • Medtech startup company that has developed novel surface modification technologies to treat dental/orthopedic implant failures.
  • Electrodes for applying pulsed electric fields to skin lesions
  • Minimally invasive, laparoscopic surgery including hysterectomy.
  • Device treatments for cerebral aneurysms.
  • Handheld device to provide early detection of amblyopia and strabismus.
  • Infrared technology used adjectively with surgical tools to detect accidental damage to blood vessels.
  • Patient positioning systems for the orthopedic surgical suite.
  • Undetermined
  • Products for the treatment of heart failure
  • Tissue regeneration in bone and cartilage/osteochondral tissue.
  • Developing nonsurgical, catheter-delivered repair of the mitral valve.
  • Prosthetic valves.
  • Believed to be development technology(s) for the treatment of mitral valve defects.
  • Office-based catheter removal of small kidney stones that are otherwise left untreated.
  • Medical device startup developing a minimally invasive surgical procedure for the lacrimal glands.
  • Development of biomaterials for bone grafting.
  • Device for treatment of gastroesophageal reflux disease (GERD)
  • Early-stage medical device company developing advanced imaging technologies for minimally invasive surgery.
  • Medical device devleopment company focused on minimally invassive surgery.
  • Percutaneous treatment of mitral valve disease.
  • Hyperthermia treatment of cancer.
  • Neurostimulators for pain management.
  • Wound healing products based on a proprietary polymer technology.
  • Debridement of toenails in diabetic and other populations.
  • Decision support tool to predict patients’ blood glucose profile and enable user-driven changes to normalize blood glucose levels.
  • Developing devices for mitral valve repair.
  • Device for compression anastomosis in colorectal surgery.
  • Magnetically compression anastomosis as an alternative to surgical staplers.
  • Patient positioning for surgery based on peripheral nerve stimulation.
  • Hemodynamic monitor designed for high-risk patients in the OR and ICU.
  • Hysteroscopic morcellator to remove uterine fibroids.
  • EEG and ECG devices for monitoring respiratory and cardiovascular function.
  • Device to monitor and predict post-operative ileus after abdominal surgery.
  • Device for treatment of female urinary incontinence.
  • Device to apply gaseous nitric oxide to treat chronic diabetic foot ulcers.
  • Biotech developing small molecules and antibodies for treatments in vascular disease and enhancement of wound healing.
  • Nanotechnology based rapid diagnosis of bacterial infection.
  • Provides medical device design and development services, such as for hemostasis sealing device for use during interventional catheterization procedures.
  • Device for the treatment of hypertension.
  • Joint venture between DuPont and Royal DSM N.V. to develop surgical sealants, adhesion barriers and tissue adhesives.
  • 3D imaging, flow and pressure in cardiac diagnostics for heart failure.
  • Products for trauma including clamp to address massive hemorrhage.

 

 

Leave a Reply